Patent · US Active

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

US11413306B2 · kind B2 · utility

0Cited by

2References

12Claims

0Family size

Assignee

AlgiPharma AS · NO

Inventors

Arne Dessen · Røyken, NO
Philip Rye · Oslo, NO

Key dates

Filing date	Oct 6, 2016
Grant date	Aug 16, 2022
Priority date	—
Expiry date	Oct 6, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a method for the treatment or prevention of microbial overgrowth in at least part of the intestinal tract of a subject, said method comprising administering an effective amount of an alginate oligomer to a subject in need thereof. Also provided is an alginate oligomer for use in the treatment or prevention of microbial overgrowth in at least part of the intestinal tract of a subject and a product containing an alginate oligomer and further pharmaceutical for the treatment of intestinal microbial overgrowth and/or a CFTR modulator as a combined preparation for separate, simultaneous or sequential use in the treatment or prevention of microbial overgrowth in at least part of the intestinal tract of a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.